11 – 20 of 152
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
From flicker to FLASH: Exploring FLASH and conventional radiotherapy in experimental glioblastoma
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Geometric impact and dose estimation of on-patient placement of a lightweight receiver coil in a clinical magnetic resonance imaging-only radiotherapy workflow for prostate cancer
(
- Contribution to journal › Article
-
Mark
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Evaluating patient reported outcomes and experiences in a novel proton beam clinic – challenges, activities, and outcomes of the ProtonCare project
(
- Contribution to journal › Article
-
Mark
Combined anti-C1-INH and radiotherapy against glioblastoma
(
- Contribution to journal › Article
-
Mark
Predictive biomarkers in radioresistant rectal cancer : A systematic review
(
- Contribution to journal › Scientific review
-
Mark
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma
(
- Contribution to journal › Article
-
Mark
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
(
- Contribution to journal › Article
-
Mark
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
(
- Contribution to journal › Article